<DOC>
	<DOCNO>NCT00290992</DOCNO>
	<brief_summary>Primary : To estimate efficacy SR29142 pediatric patient newly diagnose hematological malignancy high risk Tumor Lysis Syndrome , evaluation plasma uric acid concentration . Secondary : To investigate safety population anti-SR29142 antibody , anti-SCP antibody , pharmacokinetic parameter .</brief_summary>
	<brief_title>Rasburicase Hyperuricemia</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Hyperuricemia</mesh_term>
	<mesh_term>Rasburicase</mesh_term>
	<criteria>&lt; 18 year age Patient newly diagnose hematological malignancy present hyperuricemia : Uric acid &gt; 7.5 mg/dL patient ≥ 13 year old Uric acid &gt; 6.5mg/dL patient &lt; 13 year old Or , patient newly diagnose hematological malignancy present high tumor burden define : NonHodgkin 's lymphoma , Stage IV regardless uric acid level , NonHodgkin 's Lymphomas stage III regardless uric acid level one following : At least one lymph node mass &gt; 5 cm diameter LDH ≥ 3 x ULN ( IU/L ) : Judging accord modify Murphy 's classification Acute leukemia white blood cell count ( WBC ) ≥ 50,000/mm3 LDH ≥ 3 x ULN ( IU/L ) regardless uric acid level . etc . Patients receive scheduled receive investigational drug 30 day prior start SR29142 administration trial period . Low birth weight infant ( &lt; 2500g ) gestational age &lt; 37 week Patients receive scheduled allopurinol within 72 hr prior first dose SR29142 trial period . Known history severe allergic reaction and/or severe asthma . Known history family history glucose6phosphate dehydrogenase deficiency . Known history hemolysis methemoglobinemia . Severe disorder liver kidney . ALT ( GPT ) &gt; 5.0 x ULN , Total Bilirubin &gt; 3.0 x ULN , Creatinine &gt; 3.0 x ULN Uncontrollable infection ( include viral infection ) . Known positive test HBs antigen , HCV antibody , HIV1 , 2 antibody . etc .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>urate oxidase , hyperuricemia , lymphoma , leukemia</keyword>
</DOC>